Insider Transactions in Q4 2025 at Incyte Corp (INCY)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 19
2025
|
Thomas Tray Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,774
-10.77%
|
$277,400
$100.0 P/Share
|
|
Dec 19
2025
|
Thomas Tray Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,774
+5.23%
|
$263,530
$95.76 P/Share
|
|
Dec 18
2025
|
Thomas Tray Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
600
-2.55%
|
$58,800
$98.25 P/Share
|
|
Dec 17
2025
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Open market or private sale
|
Direct |
4,323
-13.58%
|
$419,331
$97.26 P/Share
|
|
Dec 16
2025
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Open market or private sale
|
Direct |
54,008
-31.76%
|
$5,238,776
$97.36 P/Share
|
|
Dec 11
2025
|
Patrick A Mayes EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
255
-0.42%
|
$23,970
$94.94 P/Share
|
|
Dec 10
2025
|
Patrick A Mayes EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,553
-8.44%
|
$527,535
$95.58 P/Share
|
|
Dec 08
2025
|
Herve Hoppenot Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,843
-0.86%
|
$272,928
$96.7 P/Share
|
|
Dec 02
2025
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,105
-24.15%
|
$2,050,710
$102.51 P/Share
|
|
Dec 01
2025
|
Richard A. Hoffman EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
9,466
+50.0%
|
-
|
|
Dec 01
2025
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
326
-0.38%
|
$33,252
$102.04 P/Share
|
|
Dec 01
2025
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,093
-17.04%
|
$1,743,486
$102.04 P/Share
|
|
Dec 01
2025
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,559
-2.49%
|
$261,018
$102.96 P/Share
|
|
Nov 24
2025
|
Thomas Tray Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
600
-2.48%
|
$61,800
$103.0 P/Share
|
|
Nov 21
2025
|
Thomas Tray Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
169
-0.69%
|
$17,238
$102.0 P/Share
|
|
Nov 17
2025
|
Sheila A. Denton EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
278
-1.04%
|
$28,912
$104.36 P/Share
|
|
Nov 17
2025
|
Sheila A. Denton EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
278
+1.02%
|
$17,792
$64.25 P/Share
|
|
Nov 10
2025
|
Herve Hoppenot Director |
SELL
Open market or private sale
|
Direct |
187,500
-36.26%
|
$19,687,500
$105.46 P/Share
|
|
Nov 05
2025
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,233
-4.84%
|
$533,766
$102.2 P/Share
|
|
Nov 05
2025
|
Steven H Stein EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,233
+1.6%
|
$476,203
$91.78 P/Share
|
|
Nov 04
2025
|
Sheila A. Denton EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
598
-2.2%
|
$60,398
$101.36 P/Share
|
|
Nov 04
2025
|
Sheila A. Denton EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
598
+2.15%
|
$34,684
$58.06 P/Share
|
|
Nov 03
2025
|
Lee Heeson EVP, Head of Incyte Intl |
SELL
Open market or private sale
|
Direct |
3,074
-9.51%
|
$288,956
$94.02 P/Share
|
|
Oct 15
2025
|
Sheila A. Denton EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
277
-1.03%
|
$23,545
$85.13 P/Share
|
|
Oct 15
2025
|
Sheila A. Denton EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
277
+1.02%
|
$17,728
$64.25 P/Share
|
|
Oct 03
2025
|
Sheila A. Denton EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
3,501
-11.64%
|
$297,585
$85.54 P/Share
|
|
Oct 02
2025
|
Sheila A. Denton EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,130
-9.43%
|
$269,180
$86.28 P/Share
|
|
Oct 02
2025
|
Sheila A. Denton EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
599
-1.77%
|
$52,113
$87.65 P/Share
|
|
Oct 02
2025
|
Sheila A. Denton EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
599
+1.74%
|
$34,742
$58.06 P/Share
|
|
Oct 01
2025
|
Lee Heeson EVP, Head of Incyte Intl |
SELL
Payment of exercise price or tax liability
|
Direct |
463
-1.41%
|
$39,818
$86.7 P/Share
|
|
Oct 01
2025
|
Patrick A Mayes EVP & Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,569
-2.33%
|
$134,934
$86.7 P/Share
|